Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
97.732,75
-0,05%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Evoke Pharma Inc (EVOK) Evoke Pharma Inc (EVOK) Notizie

Evoke Pharma Inc

EVOK
4,2001
-0,2999 (-6,66%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202422:33EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/11/202422:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/11/202415:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:13EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEEvoke Pharma, Inc. Reports Third Quarter 2024 Financial..
06/11/202422:31EDGAR2Form SC 13D/A - General Statement of Acquisition of..
28/10/202413:10EDGAR2Form 8-K - Current report
28/10/202412:00GLOBEEvoke Pharma & EVERSANA Announce Statistically Significant..
23/10/202414:30GLOBEEvoke Pharma to Showcase Award-Winning Research at the 2024..
22/10/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/10/202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/10/202415:00EDGAR2Form 8-K - Current report
22/10/202414:30GLOBEEvoke Pharma Announces the Appointment of Ben Smeal to the..
17/10/202422:15EDGAR2Form 8-K - Current report
01/10/202422:53EDGAR2Form SC 13D/A - General Statement of Acquisition of..
01/10/202414:30GLOBEEvoke Pharma Announces Proceeds from Existing Warrants and..
27/9/202423:11EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/9/202423:08EDGAR2Form 8-K - Current report
21/9/202401:28EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
19/9/202420:20GLOBEEvoke Pharma Reaffirms Its Commitment to Patients with..
09/9/202414:30GLOBEEvoke Pharma to Participate in Gastroenterology and..
04/9/202415:20GLOBEEvoke Pharma to Present at H.C. Wainwright’s 26th Annual..
29/8/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
16/8/202413:00EDGAR2Form 8-K - Current report
13/8/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
13/8/202414:20EDGAR2Form 8-K - Current report
13/8/202414:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202414:00GLOBEEvoke Pharma, Inc. Reports Second Quarter 2024 Financial..
08/8/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202414:30GLOBEEvoke Pharma, Inc. Supports Gastroparesis Awareness Month
01/8/202413:00EDGAR2Form 8-K - Current report
30/7/202414:30GLOBEEvoke Pharma, Inc. Announces Reverse Stock Split
20/6/202413:01EDGAR2Form 8-K - Current report
17/6/202414:30GLOBEEvoke Pharma Reports Commercial Strategy Progress & Positive..
07/6/202414:00EDGAR2Form 8-K - Current report
24/5/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:02GLOBEEvoke Pharma to Present Additional GIMOTI Healthcare..
14/5/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:15GLOBEEvoke Pharma Reports First Quarter 2024 Financial Results
14/5/202422:15EDGAR2Form 8-K - Current report
14/5/202422:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
14/5/202422:00EDGAR2Form 8-K - Current report
17/4/202414:30GLOBEEvoke Pharma to Host Virtual Key Opinion Leader (KOL)..
21/3/202421:15GLOBEEvoke Pharma Announces Senior Leadership Transition with..
14/3/202421:05GLOBEEvoke Pharma Reports Fourth Quarter and Full Year 2023..
07/3/202422:10GLOBEEvoke Pharma to Report Fourth Quarter and Full Year 2023..
Apertura: 4,50 Min: 4,33 Max: 4,5992
Chiusura: 4,50

La tua Cronologia

NASDAQ
EVOK
Evoke Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network